
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.
over 9 years ago
Brand of the Year: A Retrospectiveover 9 years ago
Portfolio Management Health Checkover 9 years ago
Launch for Long-Term Successover 9 years ago
Merck’s Latest Shot Against Shinglesover 9 years ago
Measuring the Value of Prescription Drugsover 9 years ago
New Life in European Drug Pricing Spatover 9 years ago
Country Report: Switzerland





